Moderna: Summary

Moderna

Biotechnology, Pharmaceutical

Pioneering mRNA technology, delivering the greatest possible impact to people through mRNA medicines

Moderna is a biotechnology company that specializes in developing and delivering mRNA medicines to treat and prevent diseases.

mRNA pipeline, rapid design and testing of multiple mRNAs, novel production methods, accessible medicine for all

mRNA medicines can be used to treat and prevent diseases in a different way than traditional medicine by prompting the immune system to create the tools needed.

Pioneering mRNA technology, rapid design and testing of multiple mRNAs, novel production methods, accessible medicine for all

N/A

Pioneering mRNA technology, rapid design and testing of multiple mRNAs, novel production methods, accessible medicine for all

Moderna's mission is to deliver the greatest possible impact to people through mRNA medicines.

Moderna's audience includes health care professionals, investors, and the general public.

Join us and change the world of medicine, Learn more about us, Read our blog, Meet more team members, Read our 2023 ESG Report, Join our team

News and media coverage, awards, partnerships with strategic collaborators, team members with impressive backgrounds and achievements.

Innovative, pioneering, impactful, accessible

FDA approval, 12 years of progress, 45 development programs, 35 ongoing clinical trials, partnerships with strategic collaborators

Moderna differentiates itself from competitors by using mRNA technology to develop and deliver medicines, as well as its rapid design and testing capabilities.

Moderna positions itself as a biotechnology company that is revolutionizing the way diseases are treated and prevented through mRNA medicines.

2010-01-01

• Derrick Rossi

• Kenneth Chien

• Noubar Afeyan

• Robert Langer